AtriCure, Inc.
Nasdaq · Surgical & Medical Instruments & Apparatus
Company Overview
A concise company profile alongside the latest public filing activity.
AtriCure develops and sells surgical devices used to treat atrial fibrillation and to manage related risks such as stroke, including ablation systems and left atrial appendage exclusion devices used by cardiac surgeons.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Dahlquist Karl S.Chief Legal Officer | Sell | $458K | 9,370at $48.89 | Aug 24, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
| Member | Chamber | Type | Amount | Date |
|---|---|---|---|---|
| Gilbert CisnerosCA31 | House | Buy | $1,001 - $15,000 | Aug 20, 2026 |
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable ATRC activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.